Cloud-clone
SKU:RPD466Hu02
Recombinant Hypoxia Inducible Factor 2 Alpha (HIF2a)
Recombinant Hypoxia Inducible Factor 2 Alpha (HIF2a)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPD466Hu02
Organism Species
Homo sapiens (Human).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Nucleus
Predicted Molecular Mass
40.1kDa
Accurate Molecular Mass
40kDa(Analysis of differences refer to the manual)
Residues & Tags
Lys29~Ile347 with N-terminal His Tag
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Traits
Freeze-dried powder
Purity
> 95%
Isoelectric Point
6.5
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Neuro Oncol | Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling PubMed: 26409567 |
| Clinical Trials in Degenerative Diseases | Correlating oxidative stress-related factors with bone metabolic markers in older adult male patients exhibiting degenerative osteoporosis in the high-altitude hypoxic area of China: study protocol for a non-randomized controlled trial issn:2542-3975 |
| Journal of Physiological Anthropology | Telomere elongation protects heart and lung tissue cells from fatal damage in rats exposed to severe hypoxia Pubmed:29454386 |
| Oxidative damage and iron dyshomeostasis in thalassemic patients | |
| Neuropsychiatric Disease and Treatment | The Association Between Hypoxia Improvement and Electroconvulsive Therapy for Major Depressive Disorder 34588778 |
